Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
2(7%)
Results Posted
38%(5 trials)

Phase Distribution

Ph phase_2
4
14%
Ph phase_4
1
4%
Ph not_applicable
18
64%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution23 total trials
Phase 2Efficacy & side effects
4(17.4%)
Phase 4Post-market surveillance
1(4.3%)
N/ANon-phased studies
18(78.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.5%

13 of 17 finished

Non-Completion Rate

23.5%

4 ended early

Currently Active

2

trials recruiting

Total Trials

28

all time

Status Distribution
Active(3)
Completed(13)
Terminated(4)
Other(8)

Detailed Status

Completed13
unknown8
Withdrawn4
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
28
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (17.4%)
Phase 41 (4.3%)
N/A18 (78.3%)

Trials by Status

withdrawn414%
completed1346%
not_yet_recruiting14%
unknown829%
recruiting27%

Recent Activity

Clinical Trials (28)

Showing 20 of 28 trialsScroll for more
NCT07386340Not Applicable

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

Recruiting
NCT07518004Not Applicable

ROME GS System Study

Recruiting
NCT04812392Not Applicable

Physical Inactivity Impacts on Blood Vessel Health and Glucose Levels in an Aging Population

Completed
NCT06838819

CGM in Icodextrin PD

Not Yet Recruiting
NCT03808376Not Applicable

PROMISE Study: An Evaluation of an Implantable Continuous Glucose Sensor up to 180 Days

Completed
NCT06533618Not Applicable

Characterization of the "Transfusion-dependent Prediabetes" Using Continuous Glucose Monitoring

Completed
NCT03251079Not Applicable

PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm

Completed
NCT05131139Not Applicable

Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features

Unknown
NCT04776811

Evaluation of Accuracy of Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis

Completed
NCT05389254Not Applicable

Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syndrome

Unknown
NCT04369833

Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform

Completed
NCT04031599Not Applicable

Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

Completed
NCT04879693Not Applicable

Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting

Unknown
NCT04645641Not Applicable

Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

Unknown
NCT02846831Phase 2

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

Completed
NCT02846857Phase 2

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

Withdrawn
NCT03566472

The Blood Glucose Control in Patients With Type 2 Diabetes Treated With Glargine

Unknown
NCT03955107Phase 4

The Effect of Continuous Glucose Monitoring on Glycemic Control and Pregnancy Outcomes in Gestational Diabetes Mellitus

Unknown
NCT03629704

Relationship Between Blood Glucose Variability and Prognosis in Critically Ill Patients

Unknown
NCT02647905Not Applicable

Evaluation of the Accuracy of an Implanted Glucose Sensor

Completed

Drug Details

Intervention Type
DEVICE
Total Trials
28